Accueil/Actions/BMY

BMY

USD

Bristol-Myers Squibb Company Common Stock

$45.590+0.100 (0.220%)

Prix en Temps Réel

Healthcare

Drug Manufacturers - General

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$45.490

Haut

$46.590

Bas

$45.380

Volume

9.01M

Fondamentaux de l'Entreprise

Capitalisation Boursière

92.8B

Industrie

Drug Manufacturers - General

Pays

United States

Statistiques de Trading

Volume Moyen

14.51M

Bourse

NYQ

Devise

USD

Intervalle sur 52 Semaines

Bas $42.52Actuel $45.590Haut $63.33

Actualités Connexes

3 nov. 2025 · 09:55

BusinessWire

Bristol Myers Squibb Announces Cash Tender Offers to Purchase Certain Notes

Bristol-Myers Squibb Company (NYSE:BMY) ("Bristol Myers Squibb" or the "Offeror"), announced the commencement of tender offers ("Offers") to purchase for cash certain of its outstanding notes (collectively, the "Notes")

Bristol Myers Squibb Announces Cash Tender Offers to Purchase Certain Notes

30 oct. 2025 · 11:41

Reuters

Bristol Myers beats quarterly revenue estimates on strong Opdivo sales

Bristol Myers Squibb beat Wall Street estimates for third-quarter revenue on Thursday, as strong growth of its cancer immunotherapy and blood thinner Eliquis helped the drugmaker overcome a hit from generic competition for several older drugs.